M&T Bank Corp bought a new stake in shares of Houlihan Lokey, Inc. (NYSE:HLI - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 25,645 shares of the financial services provider's stock, valued at approximately $4,467,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Mayflower Financial Advisors LLC bought a new stake in Houlihan Lokey in the third quarter valued at $230,335,000. Thrivent Financial for Lutherans raised its holdings in Houlihan Lokey by 75.6% in the 3rd quarter. Thrivent Financial for Lutherans now owns 713,494 shares of the financial services provider's stock worth $146,495,000 after purchasing an additional 307,214 shares in the last quarter. Qube Research & Technologies Ltd raised its holdings in Houlihan Lokey by 153.8% in the 2nd quarter. Qube Research & Technologies Ltd now owns 274,387 shares of the financial services provider's stock worth $49,376,000 after purchasing an additional 166,285 shares in the last quarter. Capital Research Global Investors lifted its position in shares of Houlihan Lokey by 19.7% in the 3rd quarter. Capital Research Global Investors now owns 956,441 shares of the financial services provider's stock worth $196,376,000 after purchasing an additional 157,605 shares during the period. Finally, Caisse de depot et placement du Quebec lifted its position in shares of Houlihan Lokey by 411.1% in the 3rd quarter. Caisse de depot et placement du Quebec now owns 170,617 shares of the financial services provider's stock worth $35,031,000 after purchasing an additional 137,237 shares during the period. Institutional investors own 78.07% of the company's stock.
Houlihan Lokey Trading Up 0.2%
Shares of HLI stock opened at $158.32 on Monday. The company's fifty day moving average price is $152.14 and its 200-day moving average price is $170.64. The stock has a market cap of $11.05 billion, a PE ratio of 24.32, a price-to-earnings-growth ratio of 1.13 and a beta of 1.00. Houlihan Lokey, Inc. has a 12 month low of $134.41 and a 12 month high of $211.78.
Houlihan Lokey (NYSE:HLI - Get Free Report) last issued its quarterly earnings results on Thursday, January 29th. The financial services provider reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Houlihan Lokey had a net margin of 16.91% and a return on equity of 24.46%. During the same period last year, the business posted $1.64 earnings per share. The business's revenue for the quarter was up 13.0% compared to the same quarter last year. On average, sell-side analysts forecast that Houlihan Lokey, Inc. will post 7.73 earnings per share for the current fiscal year.
Houlihan Lokey Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Sunday, March 15th. Shareholders of record on Monday, March 2nd were paid a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $2.40 dividend on an annualized basis and a dividend yield of 1.5%. Houlihan Lokey's dividend payout ratio (DPR) is currently 36.87%.
Insider Buying and Selling
In other news, General Counsel Christopher M. Crain sold 500 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $143.40, for a total value of $71,700.00. Following the sale, the general counsel directly owned 500 shares of the company's stock, valued at $71,700. The trade was a 50.00% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Robert A. Schriesheim sold 5,000 shares of the company's stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $170.86, for a total value of $854,300.00. Following the completion of the sale, the director owned 27,982 shares in the company, valued at $4,781,004.52. The trade was a 15.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 22.83% of the stock is currently owned by company insiders.
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on HLI shares. Weiss Ratings lowered shares of Houlihan Lokey from a "hold (c+)" rating to a "hold (c)" rating in a research note on Tuesday, April 21st. The Goldman Sachs Group lowered their price objective on shares of Houlihan Lokey from $210.00 to $184.00 and set a "buy" rating for the company in a report on Wednesday, April 1st. Morgan Stanley cut their price objective on Houlihan Lokey from $205.00 to $193.00 and set an "overweight" rating on the stock in a research report on Thursday, April 9th. UBS Group reduced their target price on Houlihan Lokey from $196.00 to $163.00 and set a "neutral" rating on the stock in a report on Thursday, March 12th. Finally, Keefe, Bruyette & Woods decreased their target price on Houlihan Lokey from $218.00 to $214.00 and set an "outperform" rating for the company in a research report on Thursday, January 29th. Five analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, Houlihan Lokey presently has an average rating of "Moderate Buy" and a consensus target price of $197.71.
Read Our Latest Stock Analysis on HLI
About Houlihan Lokey
(
Free Report)
Houlihan Lokey, Inc is a global investment bank and financial services firm founded in 1972 and headquartered in Los Angeles, California. The company specializes in advisory services across a broad range of transaction types and financial matters. Since its founding, Houlihan Lokey has grown to serve corporations, financial sponsors, and government entities worldwide, providing expertise in complex and high-stakes engagements.
The firm's core service offerings include mergers and acquisitions advisory, capital markets advisory, financial restructuring and distressed M&A, and valuation and fairness opinions.
Recommended Stories
Want to see what other hedge funds are holding HLI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Houlihan Lokey, Inc. (NYSE:HLI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Houlihan Lokey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Houlihan Lokey wasn't on the list.
While Houlihan Lokey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report